ArticleNature biotechnology2026
A blinded, prospective benchmark of in silico antibody discovery anchored to experimental affinity and developability.
M Frank Erasmus et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it